Knowledge Base
Google Ads for Peptide Companies
Reference material on approval, compliance, Merchant Center, Shopping, tracking and campaign structure — written from audits and client work, not from Google’s help centre.
New here?
Recommended Reading Sequence
Six steps, in the order the work actually happens. Roughly 40 minutes end to end.
- 1Can Peptide Companies Advertise on Google?Whether you can advertise at all, and which policies decide it.
- 2Merchant CenterSetup, why catalogues get suspended, and how recovery actually works.
- 3ComplianceThe full-domain checklist we run before any account goes live.
- 4TrackingGetting a conversion signal that bidding can safely rely on.
- 5Google ShoppingFeed strategy and campaign structure once Merchant Center is stable.
- 6Launch ProgramHow the seven stages come together as a single engagement.
The Peptide Google Ads Readiness Score scores your business across policy, website transparency, Merchant Center, tracking and acquisition economics, and tells you which of these articles to read first.
Can Peptide Companies Advertise on Google Ads? (Updated November 2026)
Whether peptide companies can run Google Ads in 2026, by business type: which policies apply, what changed since October 2025, and what to check befor…
Merchant Center for Peptides: Setup, Suspensions and Recovery (2026 Guide)
How Merchant Center reviews peptide stores, the two policies to check first after a suspension, how review requests and warning periods work, and when…
The Google Misrepresentation Policy, Explained for Peptide Advertisers
Misrepresentation is the most common peptide suspension reason, and the least explained. What reviewers look for, and how to make a site verifiably tr…
Google Ads for Research Peptides: Campaign Structure That Holds Up
Keyword strategy, negative lists, and campaign structure for research peptide suppliers, built around intent separation rather than volume.…
Peptide Google Shopping: Feed Strategy and Campaign Structure
How to build a peptide product feed that survives review and performs, plus when Standard Shopping beats Performance Max for this category.…
Conversion Tracking for Peptide Ecommerce (Without Fooling Yourself)
A tracking build for peptide stores: single source of truth, enhanced conversions, consent handling, and the double-counting patterns that quietly bre…
The Google Ads Compliance Checklist for Peptide Companies
A practical, page-by-page compliance checklist for peptide websites and Google Ads accounts, in the order we run it during an audit.…
How Long Does Google Ads Approval Take for Peptide Companies?
Realistic timelines for advertiser verification, ad review, Merchant Center review and suspension recovery for peptide companies, and what makes each …
Do You Need LegitScript Certification to Run Google Ads? (And What Happens After)
Which peptide, telehealth and pharmacy businesses need LegitScript certification for Google Ads, what it costs, what changed for prescription drug ter…
Can You Advertise Compounded GLP‑1s on Google Ads?
What Google's restricted drug term rules mean for compounded semaglutide and tirzepatide, why keyword targeting is the real wall, and how GLP-1 clinic…
Performance Max for Peptide and Telehealth Accounts: Worth the Risk?
Whether Performance Max belongs in a compliance-sensitive peptide or telehealth account, which 2026 controls finally make it manageable, and how to ru…
HIPAA‑Conscious Conversion Tracking for Telehealth Google Ads
How telehealth and peptide clinics track Google Ads conversions without sending patient data to Google: Consent Mode v2, enhanced conversions, server-…
How Much Should a Peptide or Telehealth Clinic Spend on Google Ads?
A budget model built from your own numbers — customer value, close rate and target payback — instead of borrowed benchmarks, plus what a r…
Why Merchant Center Suspends Peptide Stores: The 6 Triggers to Check First
The six Merchant Center policy triggers behind peptide store suspensions, how to tell which one you actually hit from the notice, and why the fix diff…
The Peptide Site Remediation Checklist: What to Fix Before You Appeal
A 40-point, domain-wide remediation checklist for peptide websites before a Merchant Center or Google Ads appeal: identity, policies, product claims, …
Unapproved Substances: How Google Applies the Policy to Peptide Keywords, Ad Text and Landing Pages
How Google's Unapproved Substances policy is actually applied to peptide advertisers across three surfaces: keywords, ad text and assets, and landing …
Payment Processing for Peptide Companies: How High-Risk Underwriting Actually Works
How acquirers underwrite peptide merchants: why mainstream processors decline or close accounts, MCC classification, reserves, card-network chargeback…
Tagada for Peptide Companies: What It Is, What It Publishes, and What We Could Not Verify
An evidence-based operator profile of Tagada and TagadaPay for peptide businesses: products, published terms, reserves, fees, peptide onboarding, Goog…
Product Disapproval vs. Account Suspension in Merchant Center: What Peptide Stores Should Fix First
How to tell a Merchant Center product-level disapproval from an account-level warning or suspension, what each one means for a peptide store, which to…
Manual Feeds for Peptide Catalogues: When to Stop Relying on the App Sync
When a peptide store should replace its Shopify or WooCommerce app sync with a manual Merchant Center feed (file, Google Sheets or Merchant API), when…
How to Write a Google Ads or Merchant Center Appeal That Gets Read
A practical guide to Google Ads and Merchant Center appeals for peptide businesses: which appeal channel you are in, fixed vs disagree, a five-part st…
Account Recovery After a Google Suspension: Realistic Sequencing and Timelines for Peptide Businesses
How peptide businesses should sequence recovery after a Google Ads or Merchant Center suspension: which account to appeal first, the order of operatio…
Remedora for Peptide Companies: What It Is, What It Publishes, and What We Could Not Verify
An evidence-based operator profile of Remedora, the all-in-one telehealth platform, for peptide businesses: what it offers, where peptides fit, publis…
Shopping Ads vs. Free Listings for Peptide Stores: Eligibility, Risk and What Actually Differs
How Google Shopping ads and free listings differ for peptide stores in 2026: one consolidated policy set, what free listings need, which disapprovals …
Tagada vs. Remedora for Peptide Companies: Different Categories, Compared on the Evidence
An evidence-based comparison of Tagada and Remedora for peptide businesses: what each actually is, which business model each fits, published pricing a…
Stripe Alternatives for Peptide Companies: What Each Option Actually Is, Using Their Own Published Rules
What peptide companies can use instead of Stripe, grounded in each provider's own published rules: why PayPal, Braintree, Square, Adyen, Shopify Payme…
Ecommerce Platforms for Peptide Businesses: Shopify, WooCommerce, BigCommerce and Headless, Read Against Their Own Terms
How Shopify, WooCommerce, BigCommerce and headless or custom builds treat peptide businesses, based on each platform's own acceptable use and payment …
Landing Page CRO for Peptide Stores: What You Can Test, What You Can’t, and Why
How to improve conversion on peptide landing and product pages without creating Google Ads, Merchant Center, payment or FDA risk: what the August 2026…
Bidding on Competitor Brand Names in Peptide Google Ads: What Google Allows and Where the Legal Risk Sits
Can a peptide company bid on a competitor’s brand name in Google Ads? What Google’s Trademarks policy restricts, what 2024 US appeals cour…
Certificates of Analysis on Peptide Sites: How to Publish Testing Evidence Without Creating Claims Risk
How peptide companies should publish certificates of analysis so they support Google Ads, Merchant Center and payment reviews instead of undermining t…
Microsoft Advertising for Peptide Companies: Is Bing Easier Than Google? What the 2026 Policies Say
Is Microsoft Advertising (Bing) a workaround for peptide companies blocked on Google? What Microsoft’s Healthcare and Pharmaceutical Ad Policy (…
Google Ads for TRT and HRT Clinics: Certification, Controlled-Substance Rules and the December 2026 DEA Deadline
What testosterone and hormone therapy clinics need before running Google Ads: which business models need LegitScript and Google healthcare certificati…
Conversion Tracking With a Hosted Checkout: Fixing Lost Purchases in Google Ads and GA4 for Peptide Stores
High-risk processors often send peptide buyers to a hosted payment page on another domain. How that breaks Google Ads and GA4 purchase tracking, and a…
HHS’s Peptide Compounding Policy: The 6 Peptides Covered and the 10 Conditions
HHS published its enforcement discretion policy for 503A compounding of BPC-157, TB-500, KPV, MOTS-c, semax and epitalon on 30 October 2026. The cover…
How to Verify a Peptide COA: Match the Lot, Report and Laboratory
A step-by-step method for checking a peptide certificate of analysis: match the lot on your vial to the report, confirm the report ID with the issuing…
Comparing Peptide Wholesale Programs: Documentation, Lot Traceability and Commercial Terms
How three peptide wholesale programs compare on documented MOQ, pricing basis, lot reservation, lead times, COAs and private-label terms, read from th…
Simple Life Science: New Research Peptide and API Brand (Launched October 2026)
Simple Life Science is a research-use peptide, API and custom-synthesis brand launched in October 2026 by Melex Technologies, the operator of Simple P…
Pepti (HelloPepti.com): New Peptide Telehealth Platform (Launched September 2026)
Pepti LLC launched HelloPepti.com, a US telehealth platform for physician-prescribed compounded peptides, with a September 2026 rollout. What it says …
StackLab (withstacklab.com): New Compounded GLP-1 Telehealth Platform (Launched October 2026)
StackLab launched on 12 October 2026 as a US telehealth platform for compounded semaglutide and tirzepatide, with a wider peptide menu announced. What…
Research-Use-Only vs Compounded vs FDA-Approved Peptides: What Is the Difference?
The same peptide name can be sold three ways: as a research chemical, as a compounded prescription, or as an FDA-approved drug. Who regulates each, wh…
Is BPC-157 Legal? Its US Regulatory Status After the HHS Policy (November 2026)
BPC-157 is not FDA-approved and not on the 503A bulks list. Since 30 October 2026, HHS has said it will not take enforcement action against 503A compo…
HPLC, Mass Spec, Endotoxin: What the HHS Peptide Testing Standard Asks a COA to Show
The HHS peptide policy includes a testing standard for bulk peptide APIs used in compounding. What each test measures (HPLC assay, mass spec identity,…
503A vs 503B: Who Can Compound Peptides, and Why the HHS Policy Covers Only One
503A pharmacies compound for individual prescriptions; 503B outsourcing facilities register with FDA, follow CGMP and can supply office stock. How eac…
Phases (wearephases.com): New Women-Focused Peptide Telehealth Platform (Launched November 2026)
Phases launched on 3 November 2026 as a US telehealth platform for compounded peptide prescriptions aimed at women. Who operates it, what its site lis…
Nuvials (nuvials.com): New Arizona Research Peptide Supplier (Launched November 2026)
Nuvials, LLC launched nuvials.com on 3 November 2026 as a research-use-only peptide supplier that requires a researcher-access application before purc…
No articles match that yet. Try a broader term, or ask us directly.
Ready to See What’s Possible?
A 30-minute strategy call on your account, your site and your acquisition economics — and what it would take to grow them on Google Ads.